Mechanism
How Beractant works
Replaces deficient pulmonary surfactant, reducing alveolar surface tension and preventing alveolar collapse.
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Beractant is an exogenous surfactant used to prevent and treat neonatal respiratory distress syndrome. It lowers alveolar surface tension, improves compliance, and reduces atelectasis. Students should associate surfactant replacement with premature infants and neonatal RDS.
Mechanism
Replaces deficient pulmonary surfactant, reducing alveolar surface tension and preventing alveolar collapse.
Clinical Pearl
Think premature infant + ground glass lungs + surfactant deficiency.
Kinetics
Onset
Immediate
Peak
Rapid
Duration
Variable
NBRC-style question
A patient scenario involves premature infant with respiratory distress syndrome. Which medication concept should the respiratory therapy student recognize?
High-yield answer
Beractant = neonatal RDS
Interactive practice
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
Related study paths
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.